Developmental alterations in Huntington’s disease neural cells and pharmacological rescue in cells and mice

The HD iPSC Consortium, Lim, Ryan G, Salazar, Lisa L, Wilton, Daniel K, King, Alvin R, Stocksdale, Jennifer T, Sharifabad, Delaram, Lau, Alice L +44 more·2017·Nature Neuroscience
DOI 10.1038/nn.4532

Cited by (224)

Items 101–200 of 224

  1. Treatment with JQ1, a BET bromodomain inhibitor, is selectively detrimental to R6/2 Huntington’s disease mice
    Amanda J. Kedaigle, Jack C. Reidling, Ryan G. Lim, Miriam Adam, Jie Wu, Brook T. Wassie, Jennifer T. Stocksdale, Malcolm Casale, Ernest Fraenkel, Leslie Michels Thompson · 2019 · Human Molecular Genetics
  2. Neural In Vitro Models for Studying Substances Acting on the Central Nervous System
    Ellen Fritsche, Julia Tigges, Julia Hartmann, Julia Kapr, Melania Maria Serafini, Barbara Viviani · 2020 · Handbook of experimental pharmacology
  3. PAM-altering SNP-based allele-specific CRISPR-Cas9 therapeutic strategies for Huntington’s disease
    Jun Wan Shin, Eun Pyo Hong, Seri S. Park, Doo Eun Choi, Sophia Zeng, Richard Z. Chen, Jong‐Min Lee · 2022 · Molecular Therapy — Methods & Clinical Development
  4. Functional analysis of brain derived neurotrophic factor (BDNF) in Huntington’s disease
    Zhike Zhou, Shanshan Zhong, Rongwei Zhang, Kexin Kang, Xiaoqian Zhang, Ying Xu, Chuansheng Zhao, Mei Zhao · 2021 · Aging
  5. Unbiased identification of novel transcription factors in striatal compartmentation and striosome maturation
    Maria‐Daniela Cirnaru, Sicheng Song, Kizito‐Tshitoko Tshilenge, Chuhyon Corwin, Justyna Mleczko, Carlos Galicia Aguirre, Houda Benlhabib, Jaroslav M. Bendl, Pasha Apontes, John F. Fullard et al. · 2021 · eLife
  6. Comparison of Administration Routes on the Protective Effects of Bee Venom Phospholipase A2 in a Mouse Model of Parkinson’s Disease
    Hyunjung Baek, Hyun Il Jang, Hat Nim Jeon, Hyunsu Bae · 2018 · Frontiers in Aging Neuroscience
  7. Impaired inhibitory GABAergic synaptic transmission and transcription studied in single neurons by Patch-seq in Huntington’s disease
    Foteini Paraskevopoulou, Poorya Parvizi, Gökçe Senger, Nurcan Tunçbağ, Christian Rosenmund, Ferah Yildirim · 2021 · Proceedings of the National Academy of Sciences
  8. When repetita no-longer iuvant: somatic instability of the CAG triplet in Huntington’s disease
    Elena F. Cattaneo, Davide Scalzo, Martina Zobel, Raffaele Iennaco, Camilla Maffezzini, Dario Besusso, Simone Maestri · 2024 · Nucleic Acids Research
  9. Epigenetics and Pharmacoepigenetics of Age-Related Neurodegenerative Disorders
    Ramón Cacabelos, Pablo Cacabelos, Juan C. Carril · 2019 · Elsevier eBooks
  10. Characterization of Neurodevelopmental Abnormalities in iPSC-Derived Striatal Cultures from Patients with Huntington’s Disease
    Pranav P. Mathkar, Divya Suresh, James Dunn, Colton M. Tom, Virginia B. Mattis · 2019 · Journal of Huntington s Disease
  11. Directly Reprogrammed Huntington's Disease Neural Precursor Cells Generate Striatal Neurons Exhibiting Aggregates and Impaired Neuronal Maturation
    Ruth Monk, Kevin C. Lee, Kathryn S. Jones, Bronwen J. Connor · 2021 · Stem Cells
  12. Enhanced cerebral branched-chain amino acid metabolism in R6/2 mouse model of Huntington’s disease
    Jens Velde Andersen, Niels Henning Skotte, Blanca I. Aldana, Anne Nørremølle, Helle S. Waagepetersen · 2019 · Cellular and Molecular Life Sciences
  13. Pluripotent stem cell-derived models of neurological diseases reveal early transcriptional heterogeneity
    Matan Sorek, Walaa Oweis, Malka Nissim‐Rafinia, Moria Maman, Shahar Simon, Cynthia C. Hession, Xian Adiconis, Sean Simmons, Neville E. Sanjana, Xi Shi et al. · 2021 · Genome biology
  14. Juvenile Huntington’s Disease and Other PolyQ Diseases, Update on Neurodevelopmental Character and Comparative Bioinformatic Review of Transcriptomic and Proteomic Data
    Karolina Świtońska-Kurkowska, Bart Krist, Joanna Maria Delimata, Maciej Figiel · 2021 · Frontiers in Cell and Developmental Biology
  15. Prevention of transgene silencing during human pluripotent stem cell differentiation
    Takeshi Uenaka, Alan Napole, A. Saha, Duo Sun, Angelina Singavarapu, Elizabeth Calzada, Jiahui Chen, Lena Erlebach, Amanda McQuade, Daniel M. Ramos et al. · 2026 · Cell stem cell
  16. HD and SCA1: Tales from two 30-year journeys since gene discovery
    Leslie Michels Thompson, Harry T. Orr · 2023 · Neuron
  17. Cell Reprogramming to Model Huntington’s Disease: A Comprehensive Review
    Ruth Monk, Bronwen J. Connor · 2021 · Cells
  18. Immortalized striatal precursor neurons from Huntington’s disease patient-derived iPS cells as a platform for target identification and screening for experimental therapeutics
    Sergey Akimov, Mali Jiang, Amanda J. Kedaigle, Nicolas Arbez, Leonard O. Marque, Chelsy R. Eddings, Paul T. Ranum, Emma Whelan, Anthony Tang, Ronald S. Wang et al. · 2021 · Human Molecular Genetics
  19. Patient-Specific iPSCs-Based Models of Neurodegenerative Diseases: Focus on Aberrant Calcium Signaling
    Dmitriy A. Grekhnev, Elena V. Kaznacheyeva, Vladimir A. Vigont · 2022 · International Journal of Molecular Sciences
  20. Expanded huntingtin CAG repeats disrupt the balance between neural progenitor expansion and differentiation in human cerebral organoids
    Jinqiu Zhang, Jolene Ooi, Kagistia Hana Utami, Sarah R. Langley, Obed Akwasi Aning, Dong Shin Park, Magdalena Renner, Shiming Ma, Chit Fang Cheok, Juergen A. Knoblich et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  21. Neural Stem Cell Dysfunction in Human Brain Disorders
    Ewa Liszewska, Jacek Jaworski · 2018 · Results and problems in cell differentiation
  22. Chromatin accessibility and transcription dynamics during in vitro astrocyte differentiation of Huntington’s Disease Monkey pluripotent stem cells
    Alexandra Goodnight, Isaac Kremsky, Sujittra Khampang, Yoon Hee Jung, James M. Billingsley, Steven E. Bosinger, Victor G. Corces, Anthony W.S. Chan · 2019 · Epigenetics & Chromatin
  23. The Big Picture of Neurodegeneration: A Meta Study to Extract the Essential Evidence on Neurodegenerative Diseases in a Network-Based Approach
    Nicolas Ruffini, Susanne Klingenberg, Raoul Heese, Susann Schweiger, Susanne Gerber · 2022 · Frontiers in Aging Neuroscience
  24. ISX-9 potentiates CaMKIIδ-mediated BMAL1 activation to enhance circadian amplitude
    Huilin Li, Jiali Ou, Yaqun Li, Niannian Xu, Qing Li, Ping Wu, Chao Peng, Yun‐Chi Tang, Hung-Chun Chang · 2022 · Communications Biology
  25. Activity-Dependent Transcriptional Program in NGN2+ Neurons Enriched for Genetic Risk for Brain-Related Disorders
    Yixuan Ma, Jaroslav M. Bendl, Brigham J. Hartley, John F. Fullard, Rawan Abdelaal, Seok‐Man Ho, Roman Kosoy, Peter Gochman, Judith L. Rapoport, Gabriel E. Hoffman et al. · 2023 · Biological Psychiatry
  26. Mutant Huntingtin Affects Diabetes and Alzheimer’s Markers in Human and Cell Models of Huntington’s Disease
    Gepoliano S. Chaves, John Stanley, Nader Pourmand · 2019 · Cells
  27. Pluripotent stem cells for neurodegenerative disease modeling: an expert view on their value to drug discovery
    Shi-Dong Chen, Hong‐Qi Li, Mei Cui, Qiang Dong, Jin‐Tai Yu · 2020 · Expert Opinion on Drug Discovery
  28. An altered extracellular matrix–integrin interface contributes to Huntington’s disease-associated CNS dysfunction in glial and vascular cells
    Sarah J. Hernandez, Ryan G. Lim, Tarik Seref Onur, Mark A. Dane, Rebecca Lee Smith, Keona Q. Wang, Grace E. Jean, Andrea M. Reyes-Ortiz, Kaylyn L. Devlin, Ricardo Miramontes et al. · 2022 · Human Molecular Genetics
  29. Distinct molecular patterns in R6/2 HD mouse brain: Insights from spatiotemporal transcriptomics
    Mara S. Burns, Ricardo Miramontes, Jie Wu, Ravinder Gulia, Madhu Sudhana Saddala, Alice Lau, Tiffany Quach, John C. Reidling, Vivek Swarup, Albert R. La Spada et al. · 2025 · Neuron
  30. RUES2 hESCs exhibit MGE-biased neuronal differentiation and muHTT-dependent defective specification hinting at SP1
    Paola Conforti, Dario Besusso, Silvia Brocchetti, Ilaria Campus, Claudio Cappadona, Maura Galimberti, Angela Laporta, Raffaele Iennaco, Riccardo Lorenzo Rossi, Vittoria Dickinson Bocchi et al. · 2020 · Neurobiology of Disease
  31. RNA-seq analysis reveals significant transcriptome changes in huntingtin-null human neuroblastoma cells
    Johanna Bensalel, Hongyuan Xu, Michael L. Lu, Enrico Capobianco, Jianning Wei · 2021 · BMC Medical Genomics
  32. Altered Activity-Regulated H3K9 Acetylation at TGF-Beta Signaling Genes During Egocentric Memory in Huntington's Disease
    Rafael Alcalá‐Vida, Caroline Lotz, Baptiste Brulé, Jonathan Séguin, Charles Decraene, Ali Awada, Aurélie Bombardier, Brigitte Cosquer, Anne Pereira de Vasconcelos, Emmanuel Brouillet et al. · 2022 · Progress in Neurobiology
  33. Mutant huntingtin confers cell-autonomous phenotypes on Huntington’s disease iPSC-derived microglia
    Nina Stöberl, Jasmine Donaldson, Caroline S. Binda, Branduff McAllister, Hazel Hall‐Roberts, Lesley Jones, Thomas H. Massey, Nicholas D. Allen · 2023 · Scientific Reports
  34. Reduced Expression of GABAA Receptor Alpha2 Subunit Is Associated With Disinhibition of DYT-THAP1 Dystonia Patient-Derived Striatal Medium Spiny Neurons
    Selma Staege, Anna Kutschenko, Hauke Baumann, Hannes Glaß, Lisa M. Henkel, Thomas Gschwendtberger, Norman Kalmbach, Martin Klietz, Andreas Hermann, Katja Lohmann et al. · 2021 · Frontiers in Cell and Developmental Biology
  35. Haplotype-specific insertion-deletion variations for allele-specific targeting in Huntington's disease
    Jun Wan Shin, Aram Shin, Seri S. Park, Jong‐Min Lee · 2022 · Molecular Therapy — Methods & Clinical Development
  36. Human iPS Cell-Derived Patient Tissues and 3D Cell Culture Part 1: Target Identification and Lead Optimization
    Richard M. Eglen, Terry Reisine · 2018 · SLAS TECHNOLOGY
  37. Corticostriatal maldevelopment in the R6/2 mouse model of juvenile Huntington's disease
    Carlos Cepeda, Sandra M. Holley, Joshua Barry, Katerina D. Oikonomou, Vannah-Wila Yazon, Allison Peng, Deneen Argueta, Michael Levine · 2024 · Neurobiology of Disease
  38. HTT loss-of-function contributes to RNA deregulation in developing Huntington’s disease neurons
    Emilia Kozłowska, Agata Ciołak, Grażyna Adamek, Julia Szcześniak, Agnieszka Fiszer · 2025 · Cell & Bioscience
  39. Induced pluripotent stem cells from Huntington’s disease patients: a promising approach to define and correct disease-related alterations
    David Vı́lchez, Azra Fatima, Ricardo Gutiérrez-García · 2019 · Neural Regeneration Research
  40. Revisiting cell and gene therapies in Huntington’s disease
    Margarida Beatriz, Carla Lopes, A.C. Ribeiro, Ana Cristina Rego · 2021 · Journal of Neuroscience Research
  41. Transcriptional signatures in iPSC-derived neurons are reproducible across labs when differentiation protocols are closely matched
    Xylena Reed, Melanie M. Cobb, Gaia Skinbinski, Dorien A. Roosen, Alice Kaganovich, Jinhui Ding, Steven M. Finkbeiner, Mark Cookson · 2021 · Stem Cell Research
  42. Genome-wide screening in pluripotent cells identifies Mtf1 as a suppressor of mutant huntingtin toxicity
    Giorgia Maria Ferlazzo, Anna Maria Gambetta, Sonia Amato, Noemi Cannizzaro, Silvia Angiolillo, Mattia Arboit, Linda Diamante, Elena Carbognin, Patrizia Romani, Federico La Torre et al. · 2023 · Nature Communications
  43. (+)4-Cholesten-3-one promotes differentiation of neural stem cells into dopaminergic neurons through TET1 and FoxA2
    Sen Ye, Jun Zhong, Jiapei Huang, Saixia Zhang, Hui Li, Dongfeng Chen, Caixia Li · 2020 · Neuroscience Letters
  44. Neural stem cells derived from the developing forebrain of YAC128 mice exhibit pathological features of Huntington’s disease
    Endan Li, Hee Ra Park, Chang Pyo Hong, Young-Hoon Kim, Jiwoo Choi, Suji Lee, Hyun Jung Park, Bomi Lee, Tae Aug Kim, Seong-Jin Kim et al. · 2020 · Cell Proliferation
  45. Taming the Huntington’s Disease Proteome: What Have We Learned?
    Connor Seeley, Kimberly B. Kegel-Gleason · 2021 · Journal of Huntington s Disease
  46. Neurodegenerative brain models vs. cell replacement or restoration therapy: A review on promises and pitfalls
    Dhiraj Kumar, Md. Imtaiyaz Hassan · 2021 · Biochemical and Biophysical Research Communications
  47. Insight into the Neuroprotective Effect of Genistein-3′-Sodium Sulfonate Against Neonatal Hypoxic-Ischaemic Brain Injury in Rats by Bioinformatics
    Ting Xie, Liyan Shuang, Gaigai Liu, Shanshan Zhao, Zhidong Yuan, Hao Cai, Lixia Jiang, Zhihua Huang · 2022 · Molecular Neurobiology
  48. Intranuclear inclusions of polyQ-expanded ATXN1 sequester RNA molecules
    Ioannis Gkekas, Aimilia-Christina Vagiona, Nikolaos Pechlivanis, Georgia Kastrinaki, Katerina Pliatsika, Sebastian Iben, Konstantinos Xanthopoulos, Fotis E Psomopoulos, Miguel Angel Andrade-Navarro, Spyros Petrakis · 2023 · Frontiers in Molecular Neuroscience
  49. Age-Related Neurodegenerative Diseases: A Stem Cell’s Perspective
    B. Calvo, Pierre Schembri-Wismayer, M. B. Durán-Alonso · 2025 · Cells
  50. Modeling SARS-CoV-2 infection in individuals with opioid use disorder with brain organoids
    Moshe J. Willner, Yang Xiao, Hye Sung Kim, Xuejing Chen, Bin Xu, Kam W. Leong · 2021 · Journal of Tissue Engineering
  51. Regenerative Approaches in Huntington’s Disease: From Mechanistic Insights to Therapeutic Protocols
    Jenny Sassone, Elsa Papadimitriou, Dimitra Thomaidou · 2018 · Frontiers in Neuroscience
  52. Elevated SLC7A2 expression is associated with an abnormal neuroinflammatory response and nitrosative stress in Huntington’s disease
    Ian D. Gaudet, Hongyuan Xu, Emily Gordon, Gianna Adalia Cannestro, Michael L. Lu, Jianning Wei · 2024 · Journal of Neuroinflammation
  53. From Neuronal Differentiation of iPSCs to 3D Neural Organoids: Modeling of Neurodegenerative Diseases
    Matteo Bordoni, Valentina Fantini, Orietta Pansarasa, Cristina Cereda · 2019 · IntechOpen eBooks
  54. Functional genomics, genetic risk profiling and cell phenotypes in neurodegenerative disease
    Steven M. Finkbeiner · 2020 · Neurobiology of Disease
  55. Nuclear accumulation of host transcripts during Zika Virus Infection
    Kristoffer E. Leon, Mir Mubashir Khalid, Ryan A. Flynn, Krystal A. Fontaine, Thong Thanh Nguyen, G. Renuka Kumar, Camille R. Simoneau, Sakshi Tomar, David Jimenez‐Morales, Mariah Dunlap et al. · 2023 · PLoS Pathogens
  56. Human stem cell models of polyglutamine diseases: Sources for disease models and cell therapy
    Lang He, Chen Ning Zhao, Linliu Peng, Beisha Tang, Hong Feng Jiang · 2020 · Experimental Neurology
  57. Intersection of Redox Chemistry and Ubiquitylation: Post-Translational Modifications Required for Maintaining Cellular Homeostasis and Neuroprotection
    Emma I. Kane, Kelly L. Waters, Donald E. Spratt · 2021 · Cells
  58. Oligonucleotides Targeting DNA Repeats Downregulate Huntingtin Gene Expression in Huntington's Patient-Derived Neural Model System
    Tea Umek, Thomas Olsson, Olof Gissberg, Osama Saher, Eman M. Zaghloul, Karin E. Lundin, Jesper Wengel, Eric Hanse, Henrik Zetterberg, Dzeneta Vizlin‐Hodzic et al. · 2021 · Nucleic Acid Therapeutics
  59. Isoform-Specific Reduction of the Basic Helix-Loop-Helix Transcription Factor TCF4 Levels in Huntington’s Disease
    Kaja Nurm, Mari Sepp, Carla Castany‐Pladevall, Jordi Creus‐Muncunill, Jürgen Tuvikene, Alex Sirp, Hanna Vihma, Derek J. Blake, Esther Pérez‐Navarro, Tõnis Timmusk · 2021 · eNeuro
  60. Multimodal insights into adult neurogenesis: An integrative review of multi-omics approaches
    Jin Li, Leyi Huang, Wenjie Xiao, Jingyi Kong, Minghua Hu, Aihua Pan, Xiao‐Xin Yan, Fulian Huang, Lily Wan · 2025 · Heliyon
  61. Integrative Meta-Analysis of Huntington’s Disease Transcriptome Landscape
    Nela Pragathi Sneha, S. Akila Parvathy Dharshini, Y‐h. Taguchi, M. Michael Gromiha · 2022 · Genes
  62. Survival of iPSC-derived grafts within the striatum of immunodeficient mice: Importance of developmental stage of both transplant and host recipient
    Colton M. Tom, Shahab Younesi, Elana A. Meer, Catherine J. Bresee, Marlesa I. Godoy, Virginia B. Mattis · 2017 · Experimental Neurology
  63. Developmental Alterations in Adult‐Onset Neurodegenerative Disorders: Lessons from Polyglutamine Diseases
    Chandrakanth Reddy Edamakanti, Puneet Opal · 2021 · Movement Disorders
  64. Brain organoid models of Huntington's disease shift the focus towards neurodevelopment
    Wenqing Xu, Alessandro Prigione · 2025 · Disease Models & Mechanisms
  65. Huntington’s disease and brain development
    Sandrine Humbert, Monia Barnat · 2022 · Comptes Rendus Biologies
  66. Intersecting impact of CAG repeat and huntingtin knockout in stem cell-derived cortical neurons
    Jennifer T. Stocksdale, Matthew Joseph Leventhal, Stephanie Lam, Yuxin Xu, Yi Wang, Keona Q. Wang, Reuben Thomas, Zohreh Faghihmonzavi, Yogindra Raghav, Charlene Smith-Geater et al. · 2025 · Neurobiology of Disease
  67. Synaptic and functional alterations in the development of mutant huntingtin expressing hiPSC‐derived neurons
    Margarita C. Dinamarca, Laura Colombo, Natalia E. Tousiaki, Mathias M. Müller, Eline Pecho‐Vrieseling · 2022 · Frontiers in Molecular Biosciences
  68. Genomic architecture differences at the HTT locus associated with symptomatic and pre-symptomatic cases of Huntington’s disease in a pilot study.
    Matthew Salter, Ryan Powell, Jennifer Back, Francis Grand, Christina Koutsothanasi, Jayne Green, Ewan Hunter, Aroul Ramadass, Jurjen W. Westra, Alexandre V. Akoulitchev · 2019 · F1000Research
  69. Integrated analysis of differentially expressed genes and construction of a competing endogenous RNA network in human Huntington neural progenitor cells
    Xiaoping Tan, Yang Liu, Taiming Zhang, Shuyan Cong · 2021 · BMC Medical Genomics
  70. Mutant Huntingtin impairs neurodevelopment in human brain organoids through CHCHD2-mediated neurometabolic failure
    Paweł Lisowski, Selene Lickfett, Agnieszka Rybak‐Wolf, Stephanie Le, Werner Dykstra, Barbara Mlody, Carmen Menacho, Philipp Roth, Yasmin Richter, Linda Anna Michelle Kulka et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  71. Cerulenin partially corrects the disrupted developmental transcriptomic signature in Huntington’s disease striatal medium spiny neurons
    Carlos Galicia Aguirre, Kizito‐Tshitoko Tshilenge, Elena Battistoni, Alejandro Lopez‐Ramirez, Swati B. Naphade, Kevin Pérez, Akos A. Gerencser, Sicheng Song, Sean David Mooney, Simon Melov et al. · 2025 · Stem Cells
  72. Recent Advances in Neurodegeneration
    Antonella Borreca · 2019 · IntechOpen eBooks
  73. An integrated multi-omic analysis of iPSC-derived motor neurons from C9ORF72 ALS patients
    Loren Ornelas, Emilda Gomez, Lindsay Panther, Aaron P. Frank, Susan Lei, Berhan Mandefro, Maria G. Bañuelos, Brandon Shelley, Julia Kaye, Leandro de Araújo Lima et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  74. Zika Virus Infection Prevents Host mRNA Nuclear Export by Disrupting UPF1 Function
    Kristoffer E. Leon, Ryan A. Flynn, Mir Mubashir Khalid, Krystal A. Fontaine, Tom T. Nguyen, G. Renuka Kumar, Camille R. Simoneau, Sakshi Tomar, David Jimenez‐Morales, Mariah Dunlap et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  75. Pluripotent stem cell derived models of neurological diseases reveal early transcriptional heterogeneity
    Matan Sorek, Walaa Oweis, Malka Nissim‐Rafinia, Moria Maman, Shahar Simon, Cynthia C. Hession, Xian Adiconis, Sean Simmons, Neville E. Sanjana, Xi Shi et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  76. Distinct sub-cellular autophagy impairments occur independently of protein aggregation in induced neurons from patients with Huntington’s disease
    Karolina Pircs, Janelle Drouin‐Ouellet, Jeovanis Gil, Melinda Rezeli, Daniela A. Grassi, Raquel Garza, Yogita Sharma, Isabelle St‐Amour, Marie E. Jönsson, Pia Annette Johansson et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  77. Natural products proposed for the management of Huntington’s disease (HD): a comprehensive review
    Aya Salman, Aya H. Eid, Samar S. Khalaf, Ahmed M. El‐Dessouki, Riham A. El‐Shiekh, Shaza H. Aly · 2025 · Naunyn-Schmiedeberg s Archives of Pharmacology
  78. Abnormal neurodevelopment predisposes to cortical hyperexcitability in Huntington's disease
    Carlos Cepeda, Joshua Barry, Sandra M. Holley · 2025 · Journal of Huntington s Disease
  79. Huntingtin (HTT) interactome in regulation of DNA repair/remodeling and RNA processing pathways
    Tamara Ratovitski, Chloe D. Holland, Robert N. O’Meally, Alexey V. Shevelkin, Siddhi V Kamath, Tianze Shi, Matthew Rodriguez, Robert Norman Cole, Mali Jiang, Christopher A. Ross · 2026 · Life Science Alliance
  80. Cell Fate Engineering Tools for iPSC Disease Modeling
    Emily K.W. Lo, Patrick Cahan · 2019 · Methods in molecular biology
  81. Exposure to small molecule cocktails allows induction of neural crest lineage cells from human adipose-derived mesenchymal stem cells
    Yuzo Takayama, Yuka Akagi, Yoichiro Shibuya, Yasuyuki S. Kida · 2020 · PLoS ONE
  82. Genomic architecture differences at the HTT locus associated with symptomatic and pre-symptomatic cases of Huntington’s disease in a pilot study
    Matthew Salter, Ryan Powell, Jennifer Back, Francis Grand, Christina Koutsothanasi, Jayne Green, Ewan Hunter, Aroul Ramadass, Jurjen W. Westra, Alexandre V. Akoulitchev · 2021 · Edelweiss Psychiatry Open Access
  83. Genomic architecture differences at the HTT locus associated with symptomatic and pre-symptomatic cases of Huntington’s disease in a pilot study.
    Matthew Salter, Ryan Powell, Jennifer Back, Francis Grand, Christina Koutsothanasi, Jayne Green, Ewan Hunter, Aroul Ramadass, Jurjen W. Westra, Alexandre V. Akoulitchev · 2018 · F1000Research
  84. Single nuclei RNAseq analysis of HD mouse models and human brain reveals impaired oligodendrocyte maturation and potential role for thiamine metabolism
    Ryan G. Lim, Osama Al‐Dalahmah, Jie Wu, Maxwell P. Gold, Jack C. Reidling, Guomei Tang, Miriam Adam, David K. Dansu, Hye-Jin Park, Patrizia Casaccia et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  85. Assessment of the level of apoptosis in differentiated pseudo-neuronal cells derived from neural stem cells under the influence of various inducers
    Adele Naghshbandieh · 2024 · American Journal of Stem Cells
  86. Durable HTT silencing using non-evolved dCas9 epigenome editors in patient-derived cells
    J. Waldo, J. Halmai, Ankita Singh, Casiana E. Gonzalez, Yi-An Chen, Shaylyn A. Carthen, J. Nolta, Kyle D. Fink · 2025 · Molecular Therapy: Nucleic Acids
  87. Aberrant medial ganglionic eminence (MGE) GABAergic neurogenesis contributes to Huntington's disease pathogenesis
    Aldrín E. Molero, Gnanapackiam Sheela Devakanmalai, Yagiz Altun, Teresa Jover‐Mengual, J. Zhang, Nusrat Khan, Mark F. Mehler · 2026 · Neurobiology of Disease
  88. Integrated transcriptome analysis of Huntington’s disease iPSC-derived and mouse astrocytes implicates dysregulated synaptogenesis, actin, and astrocyte maturation
    Andrea M. Reyes-Ortiz, Edsel M. Abud, Mara S. Burns, Jie Wu, Sarah J. Hernandez, Nicolette R. Geller, Keona Q. Wang, Corey J. Schulz, Ricardo Miramontes, Alice Lau et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  89. Mutant huntingtin oligomers drive early human pathogenesis in Huntington’s disease
    Andrés Miguez, Cinta Gomis, Cristina Vila, Marta Tortajada, Sara Fernández‐García, Georgina Bombau, Mireia Galofré, Marı́a Garcı́a-Bravo, Phil Sanders, Helena Fernández-Medina et al. · 2022 · Research Square
  90. Picosecond Pulsed Electric Field-Induced Disaggregation of Polyglutamine Aggregates in Huntington’s Disease Neural Stem Cells
    Mackenzie Tardif-Kunk, Martina Zamponi, Emily Old, Augustine U. Anthony, Chandler Knox, Thomas R. Campbell, Ross A. Petrella, Patrick C. Sachs, Robert D. Bruno, Peter A. Mollica · 2025 · Research Square
  91. snRNA-seq of Huntington’s disease mice reveals vulnerability profiles of cortical cell types
    Dennis Feigenbutz, Kerstin Voelkl, Rüdiger Klein, Irina Dudanova · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  92. Maladie de Huntington: Une neuro-dégénérescence qui prend sa source dans le développement cérébral ?
    Alexandra Dürr, Sandrine Humbert · 2021 · HAL
  93. Variation of human neural stem cells generating organizer states in vitro before committing to cortical excitatory or inhibitory neuronal fates
    Nicola Micali, Suel–Kee Kim, Marcelo Diaz-Bustamante, Genevieve Stein-O’Brien, Seungmae Seo, Joo Heon Shin, Brian G. Rash, Shaojie Ma, Yanhong Wang, Nicolas A. Olivares et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  94. In vivo progressive degeneration of Huntington’s disease patient-derived neurons reveals human-specific pathological phenotypes
    Andrés Miguez, Sara Fernández‐García, Marta Tortajada, Georgina Bombau, Mireia Galofré, Marı́a Garcı́a-Bravo, Cristina Vila, Phil Sanders, Helena Fernández-Medina, Blanca Poquet et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  95. Dysfunction of cAMP-PKA-calcium signaling axis in striatal medium spiny neurons: a role in schizophrenia and Huntington’s disease pathogenesis
    Marija Fjodorova, Zoe Noakes, Daniel Cabezas de la Fuente, Adam C. Errington, Meng Li · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  96. Huntington Disease
    Harald W. Sontheimer · 2021 · Elsevier eBooks
  97. Biomaterial Control of Differentiation of Human Embryonic Stem Cells and Induced Pluripotent Stem Cells
    2019 · Royal Society of Chemistry eBooks
  98. Genomic architecture differences at the HTT locus underlie symptomatic and pre-symptomatic cases of Huntington’s disease.
    Matthew Salter, Ryan Powell, Jennifer Back, Francis Grand, Christina Koutsothanasi, Jayne Green, Ewan Hunter, Aroul Ramadass, Jurjen W. Westra, Alexandre V. Akoulitchev · 2019 · F1000Research
  99. Defective neuritogenesis in Abcd1/2 deficient rat neurons due to intrinsic and astrocyte-dependent mechanisms
    Arantxa Golbano, Luis Pardo, Carmen Menacho, Marina Rierola, Enrique Claro, Levi Benjamin Wood, Roser Masgrau, Elena Galea · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  100. Investigating the Gliogenic Genes and Signaling Pathways in the Pathogenesis of Huntington’s Disease: A Systematic Review
    Ovais Shafi, Raveena, Úzair Yaqoob, Madiha Haseeb, Manwar Madhwani, Luqman Naseer Virk, Syed Wajahat Ali Zaidi, Ammar Nadeem · 2024 · Research Square